Cited by 1,226Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsAging, Health, and Disability

The DOI matches its Crossref record.

Prevalence of Alzheimer's Disease in a Community Population of Older Persons: Higher Than Previously Reported

Evans, Denis A.·1989·JAMA

DOI 10.1001/jama.1989.03430180093036

Open this paper in CoChat — free account

Abstract

Clinically diagnosed Alzheimer's disease and other dementing illnesses were assessed in a geographically defined US community. Of 3623 persons (80.8% of all community residents over 65 years of age) who had brief memory testing in their homes, a stratified sample of 467 persons underwent neurological, neuropsychological, and laboratory examination. Prevalence rates of Alzheimer's disease were calculated for the community population from the sample undergoing clinical evaluation. Of those over the age of 65 years, an estimated 10.3% (95% confidence limits, 8.1% and 12.5%) had probable Alzheimer's disease. This prevalence rate was strongly associated with age. Of those 65 to 74 years old, 3.0% (95% confidence limits, 0.8 and 5.2) had probable Alzheimer's disease, compared with 18.7% (95% confidence limits, 13.2 and 24.2) of those 75 to 84 years old and 47.2% (95% confidence limits, 37.0 and 63.2) of those over 85 years. Other dementing conditions were uncommon. Of community residents with moderate or severe cognitive impairment, 84.1% had clinically diagnosed Alzheimer's disease as the only probable diagnosis. These data suggest that clinically diagnosed Alzheimer's disease is a common condition and that its public health impact will continue to increase with increasing longevity of the population. (JAMA. 1989;262:2551-2556)

Integrity signals

Registry

Crossref · 10.1001/jama.1989.03430180093036

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 801–900 of 1,000

Cholinergic Nicotinic Systems in Alzheimer??s Disease
Vesey, R., Birrell, J. M., Bolton, C., Chipperfield, R. S., Blackwell, A. D., Dening, T., & Sahakian, B. J. (2002) · CNS Drugs · doi:10.2165/00023210-200216070-00005 · Cited by 11
Prevention and Therapy of Neurodegenerative Disorders: Role of Nutritional Antioxidants
Matteo, V. D., Pierucci, M., Giovanni, G. D., & Esposito, E. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50168-x · Cited by 11
MANAGING THE CARE OF PATIENTS WITH IRREVERSIBLE DEMENTIA DURING HOSPITALIZATION FOR COMORBIDITIES
Stolley, J. M., Hall, G. R., Collins, J., Bleuer, N., Adrian, C., & Buckwalter, K. C. (1993) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02905-x · Cited by 11
Severely Demented Elderly People A Case Against Senicide
Post, S. G. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb01434.x · Cited by 11
Implications of Amyloid Precursor Protein and Subsequent β‐Amyloid Production to the Pharmacotherapy of Alzheimer's Disease
Rojas‐Fernandez, C. H., Chen, M., & Fernández, H. L. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.17.1547.34116 · Cited by 11
Galantamine in the Treatment of Vascular Dementia
Brashear, H. R. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203009189 · Cited by 11
Mental Health Issues in Elderly African Americans
Baker, F. M. (1995) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30304-5 · Cited by 11
Anatomic and Physiologic Imaging of Alzheimer’s Disease
Giacometti, A. R., Davis, P. C., Alazraki, N. P., & MALKO, J. A. (1994) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30346-x · Cited by 11
Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias
Masterman, D. M. (2004) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2003.11.002 · Cited by 10
Participation of Chronically Ill Older Adults in Their Life-Prolonging Treatment Decisions: Rights and Opportunity
Shidler, S. (1998) · Canadian Journal on Aging / La Revue canadienne du vieillissement · doi:10.1017/s0714980800010321 · Cited by 11
Opportunities for Improving Community Mental Health Services for Elderly Persons
Colenda, C. C., & Dooren, H. V. (1993) · Psychiatric Services · doi:10.1176/ps.44.6.531 · Cited by 11
The Normative Crises of Families Confronting Dementia
Kuhn, D. R. (1990) · Families in Society The Journal of Contemporary Social Services · doi:10.1177/104438949007100801 · Cited by 11
Cancer-Related Cognitive Impairment and the Potential of Dietary Interventions for the Prevention and Mitigation of Neurodegeneration
Crowder, S. L., Gudenkauf, L. M., Hoogland, A. I., Han, H. S., Small, B. J., Carson, T. L., Parker, N. H., Booth‐Jones, M., & Jim, H. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-3041 · Cited by 11
Natural Product Co-Metabolism and the Microbiota–Gut–Brain Axis in Age-Related Diseases
Obrenovich, M. E., Singh, S. K., Li, Y., Perry, G. L., Siddiqui, B., Haq, W., & Reddy, V. P. (2022) · Life · doi:10.3390/life13010041 · Cited by 11
“Due to its protracted and progressive nature, AD and other neurodegen‐ erative conditions increase with age [3].”
Background
Psychological assessment of the elderly
Lengenfelder, J., Dahlman, K. L., Ashman, T. A., & Mohs, R. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-802203-0.00016-x · Cited by 12
Genetics of Alzheimer Disease
Naj, A. C., Carney, R. M., Hahn, S. E., Slifer, M. A., Haines, J. L., & Pericak‐Vance, M. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00116-6 · Cited by 11
Maintaining standardization: an update of the HUPO Brain Proteome Project
Hamacher, M., Stephan, C., Eisenacher, M., et al. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.165 · Cited by 10
Inclusion-Body Myositis Associated with Alzheimer’s Disease
Levacic, D., Peddareddygari, L. R., Nochlin, D., Sharer, L. R., & Grewal, R. P. (2013) · Case Reports in Medicine · doi:10.1155/2013/536231 · Cited by 10
“This frequency increases with each decade with a nearly fifteen-fold increase in the prevalence in individuals between 60 and 85 years [10].”
Background
Assessment and prediction of older drivers' driving performance
Nakano, Y., Sano, S., Yamakage, Y., et al. (2014) · IEEE Intelligent Vehicles Symposium · doi:10.1109/ivs.2014.6856448 · Cited by 10
Nutrition and Cognitive Function
Nicolas, A., Nourhashemi, L. F., Lanzmann‐Petithory, D., & Vellas, B. J. (2001) · Nutrition in Clinical Care · doi:10.1046/j.1523-5408.2001.00137.x · Cited by 9
Tools of the Epidemiologist
Mortimer, J. A., & Borenstein, A. R. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200607001-00004 · Cited by 11
Cognition in Schizophrenia Natural History, Assessment, and Clinical Importance
Mohs, R. C. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00120-7 · Cited by 10
“These findings can be examined in light of epidemiologic data, which indicate that clinically diagnosed Alzheimer’s Disease is present in approximately 20% of the population older than 70 years of age (Evans et al. 1989).”
Background
Chlamydia pneumoniae, APOE genotype, and Alzheimer’s disease
Hudson, A. P., Gérard, H. C., Whittum‐Hudson, J. A., Appelt, D. M., & Balin, B. J. (2000) · Springer eBooks · doi:10.1007/978-3-642-57195-4_19 · Cited by 10
The Demented Elderly in the City of Helsinki: Functional Capacity and Placement
Juva, K., Sulkava, R. O., Erkinjuntti, T., Valvanne, J., & Tilvis, R. S. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01805.x · Cited by 10
Questionable dementia: Clinical course and predictors of outcome
Devanand, D. P., Folz, M., Gorlyn, M., Moeller, J. R., & Stern, Y. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(96)84489-1 · Cited by 10
Measurement issues in preventive strategies: past, present, and future
Rudberg, M. A., Furner, S. E., & Cassel, C. K. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.6.1253s · Cited by 10
Assessing cognitive function in schizophrenics and patients with Alzheimer's disease
Mohs, R. C. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00036-l · Cited by 9
Classification of dementias based on functional morphology
Jellinger, K. A., & Bancher, C. (1994) · Key topics in brain research · doi:10.1007/978-3-7091-9376-1_2 · Cited by 10
The burden of Alzheimer's disease
Burns, A. S. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/3.supplement_2.s31 · Cited by 10
Molecular Characterization and Measurement of Alzheimer's Disease Pathology: Implications for Genetic and Environmental Aetiology
Wischik, C. M., Harrington, C. R., Mukaetova‐Ladinska, E. B., Novák, M., Edwards, P. C., & McArthur, F. K. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514306.ch16 · Cited by 10
Transgenic mice in amyloid research: an interpretive review
Teng, M.-H., & Buxbaum, J. N. (1996) · Amyloid · doi:10.3109/13506129609045521 · Cited by 11
Alzheimer’s Disease: An Overview
Dunne, T. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397045-9.00139-7 · Cited by 11
Vascular cognitive impairment: prodrome to VaD?
Mayda, A., & DeCarli, C. (2009) · Vascular Cognitive Impairment in Clinical Practice · doi:10.1017/cbo9780511575976.003 · Cited by 7
Loss of glycine receptors in the nucleus accumbens and ethanol reward in an Alzheimer´s Disease mouse model
Armijo‐Weingart, L., Martín, L. S., Gallegos, S., Araya, A., Konar-Nié, M., Fernández-Pérez, E. J., & Aguayo, L. G. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102616 · Cited by 8
Premature or pathological aging: longevity
Sgarbieri, V. C., & Pacheco, M. T. B. (2017) · Brazilian journal of food technology/Brazilian Journal of Food Technology · doi:10.1590/1981-6723.19416 · Cited by 10
Clinical aspects of indoleamine 2,3-dioxygenase (IDO)-initiated tryptophan metabolism: IDO is a target of drug discovery for various diseases
Takikawa, O. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.029 · Cited by 9
The Roy Adaptation Model and Care of Persons with Alzheimer's Disease
Thornbury, J. M., & King, L. D. (1992) · Nursing Science Quarterly · doi:10.1177/089431849200500310 · Cited by 9
Beneficial Effect of Flavone Derivatives on Aβ-Induced Memory Deficit Is Mediated by Peroxisome Proliferator-Activated Receptor γ Coactivator 1α
Arsalandeh, F., Ahmadian, S., Foolad, F., Khodagholi, F., Farimani, M. M., & Shaerzadeh, F. (2015) · International Journal of Toxicology · doi:10.1177/1091581815584165 · Cited by 9
Balancing Modern Medical Benefits And Risks
Juhn, P., Phillips, A., & Buto, K. (2007) · Health Affairs · doi:10.1377/hlthaff.26.3.647 · Cited by 9
Descriptive Epidemiology of Alzheimer’s Disease
Evans, D. A. (2019) · CRC Press eBooks · doi:10.1201/9780429260353-8 · Cited by 9
Self-citation
Magnetic Resonance Imaging of Brain Iron
Bartzokis, G. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_3 · Cited by 9
Memory Self-Appraisal and Cerebral Glucose Metabolism in Age-Associated Memory Impairment
Small, G. W., Komo, S., Rue, A. L., Kaplan, A. R., & Mandelkern, M. A. (1995) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199500320-00005 · Cited by 9
Grandfather's Gun: When Should We Intervene?
Green, R., & Kellerman, A. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb06421.x · Cited by 9
Hydergine revisited: A statistical analysis of studies showing efficacy in the treatment of cognitively impaired elderly
Ammon, R., Sharma, R., Gambert, S. R., & Gupta, K. L. (1995) · AGE · doi:10.1007/bf02434076 · Cited by 9
“The prevalence of Alzhelmet's disease has currently been estimated to be between 5%-i 0% in those over age 65 and 20%-40% of those over 85 years old (1,43,44,45).”
Background
Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine
Erkinjuntti, T. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.04455.x · Cited by 8
Leadership development in the John A. Hartford Foundation Centers of Geriatric Nursing Excellence
Beverly, C. J., Maas, M., Young, H. M., et al. (2006) · Nursing Outlook · doi:10.1016/j.outlook.2006.05.007 · Cited by 9
Monozygotic twins concordant for late‐onset probable alzheimer disease with suspected alzheimer disease in four sibs
Karlinsky, H., Berg, J. M., Lennox, A., Ray, P. N., George‐Hyslop, P. S., Farrer, L. A., Percy, M. E., Andrews, D. F., & Atack, E. A. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320440512 · Cited by 9
Psychopathology in the Aged
Fisher, J. E., Zeiss, A. M., & Carstensen, L. L. (1993) · Springer eBooks · doi:10.1007/978-1-4615-3008-4_32 · Cited by 13
Dominant susceptibility genes
Martin, G. M., Schellenberg, G. D., Wijsman, E. M., et al. (1990) · Nature · doi:10.1038/347124a0 · Cited by 9
The Co-oligomers of Aβ42 and Human Islet Amyloid Polypeptide Exacerbate Neurotoxicity and Alzheimer-like Pathology at Cellular Level
Deng, J., Liu, B., Tao, Q., Luo, Y., Zhu, Y., Huang, X., & Yue, F. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.04.002 · Cited by 8
Tau and β-Amyloid Relevant Pathology as a Central Therapeutic Target in Alzheimer’s Disease
Strużyńska, L., Adamiak, K., & Sidoryk‐Wȩgrzynowicz, M. (2026) · Biomolecules · doi:10.3390/biom16040595 · Cited by 9
“The risk of developing the disease among first-degree relatives is approximately 19%, while among second-degree relatives, it is about half that value, reaching approximately 10% [15].”
Recent Advances in the Treatment and Management of Alzheimer’s Disease: A Precision Medicine Perspective
Shukla, D., Suryavanshi, A., Bharti, S. K., Asati, V., & Mahapatra, D. K. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266299847240328045737 · Cited by 10
In vivo Acetylcholinesterase activity and Antioxidant property of Cucurbita pepo ethanolic extract in Alzheimer’s disease induced by Aluminium chloride in Sprague Dawley rat model
Yadav, R. S. P., Belle, V. S., Kumar, N., Kumar, G., & Kumar, S. N. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00178 · Cited by 8
Influencia de variables socio-sanitarias en la situación del estado cognitivo y de ánimo en los pacientes geriátricos de un centro de salud
Hervás, A., Arizcuren, M. A., de Jalón, E. G., et al. (2003) · Anales del Sistema Sanitario de Navarra · doi:10.4321/s1137-66272003000300003 · Cited by 8
Alzheimer’s disease in adults with Down syndrome
Al‐Awadi, S. A., & Elbastawisy, H. I. (2012) · Middle East Journal of Medical Genetics · doi:10.1097/01.mxe.0000422778.05483.9e · Cited by 8
“The rates of dementia in adults with intellectual disabilities without Down syndrome were equivalent to the general population rate of Alzheimer’s disease [i.e. D47% affected over the age of 85 years (Evans et al., 1989)].”
Background
Sex-related biomarkers in cardiovascular and neurodegenerative disorders.
Pietraforte, D., Straface, E., Piscopo, P., Vona, R., & Confaloni, A. (2016) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_16_02_15 · Cited by 8
“Although the incidence of AD in men and women increases robustly with age [27, 28], these age-related changes are not known, but many studies revealed that there has been surprisingly little research into the effect of sex on dementia.”
Background
Demography and Epidemiology
Asis, S. J. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-73078-3_2 · Cited by 8
Cerebral lobar microhemorrhages detection by high magnetic field susceptibility weighted image: A potential diagnostic neuroimage technique of Alzheimer’s disease
Ku, H., & Chi, N. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.02.032 · Cited by 8
Familial Amyotrophic Lateral Sclerosis and Alzheimer’s Disease
Wong, P. C., Borchelt, D., Lee, M. K., Pardo, C. A., Thinakaran, G., Martin, L. J., Sisodia, S. S., & Price, D. L. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4869-0_9 · Cited by 8
A hypothesis on the aetiology of Alzheimer's disease: Description of a model involving a misfolded chaperone
Liautard, J. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90012-4 · Cited by 7
5 Neuropeptides and neurotransmitters in Alzheimer's disease: focus on corticotrophin releasing factor
Doraiswamy, P. M., Ranga, K., Krishnan, R. R., & Nemeroff, C. B. (1991) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80097-7 · Cited by 8
Age versus ageing as a cause of dementia
Winker, M. A., Ritchie, K. A., Kildea, D., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92500-7 · Cited by 8
Cognitive impairment: Policy implications for service design
Lombardo, N. E. (1991) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331759100600203 · Cited by 8
Folate, Cognition, and Depression in the Era of Folic Acid Fortification
Miller, J. W. (2004) · Journal of Food Science · doi:10.1111/j.1365-2621.2004.tb17889.x · Cited by 8
Neuropsychological Testing
Albert, M. S. (1997) · Springer eBooks · doi:10.1007/978-1-4757-2705-0_14 · Cited by 8
Mitochondrial Medicine: The Central Role of Cellular Energetic Depression and Mitochondria in Cell Pathophysiology
Seppet, E. K., Gizatullina, Z. Z., Trumbeckaitė, S., Zierz, S., Striggow, F., & Gellerich, F. N. (2007) · Wiley eBooks · doi:10.1002/9783527621095.ch15 · Cited by 8
Ion beam analysis of the bone tissue of Alzheimer's disease patients
Robertson, J. D., Samudralwar, D. L., & Markesbery, W. R. (1992) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/0168-583x(92)95532-v · Cited by 8
Ethical issues relative to autonomy and personal control in independent and cognitively impaired elders
Rice, V. H., Beck, C. M., & Stevenson, J. S. (1997) · Nursing Outlook · doi:10.1016/s0029-6554(97)90055-5 · Cited by 7
Integrative single-cell RNA sequencing and mendelian randomization analysis reveal the potential role of synaptic vesicle cycling-related genes in Alzheimer's disease
Zeng, J., Zhang, R., Xu, H., Zhang, C., & Li, L. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100097 · Cited by 7
The Limbic System: Temporal Lobe, Prefrontal Cortex, and Learning, Memory, and Emotions
Jacobson, S., Pugsley, S., & Marcus, E. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-41816-7_16 · Cited by 8
Association between physical activity and episodic memory and the moderating effects of the apolipoprotein E ε4 allele and age
Lee, B. C., Choe, Y. M., Suh, G., Choi, I.-G., Kim, H. S., Hwang, J., Yi, D., & Kim, J. W. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1184609 · Cited by 7
“Age (Evans et al., 1989; Murman, 2015) and apolipoprotein E (APOE) ε4 allele (APOE4) (Yamazaki et al., 2019) are the strongest risk factors for biological and genetic AD, respectively.”
Background
Overview of approaches in ayurveda for neurological health and disorders
Narayana, D. B. A., Joshi, H., & Tiwari, V. H. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19084-1.00009-0 · Cited by 7
Progress in the Management of Alzheimer's Disease
Smith, A. L., & Whitehouse, P. J. (1998) · Hospital Practice · doi:10.1080/21548331.1998.11443660 · Cited by 7
Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy
Rodrigues, R., Bonda, D., Perry, G. L., Castellani, R. J., Casadesús, G., Lee, H., Lee, H. P., Wang, X., Zhu, X., Petersen, R. B., et al. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5_10 · Cited by 6
Effects of Korean Zingiber mioga R. (Flower Buds and Rhizome) Extract on Memory
조교희, 오명숙, 김효근, et al. (2014) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2014.43.10.1519 · Cited by 7
Genome scan of age‐at‐onset in the NIMH Alzheimer disease sample uncovers multiple loci, along with evidence of both genetic and sample heterogeneity
Choi, Y., Blue, E., Bird, T. D., Steinbart, E. J., Blacker, D., & Wijsman, E. M. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31220 · Cited by 7
Current Approaches to the Clinical Diagnosis of Alzheimer’s Disease
Daffner, K. R. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-005-6_2 · Cited by 9
“For the population of 85 and older, estimates of prevalence have been as high as 47% (7).”
Background
Synthesis of dammarenolic acid derivatives with a potent α-glucosidase inhibitory activity
Smirnova, I. E., Petrova, A. V., Kazakova, O. B., Minnibaeva, E. M., Fedorova, A. A., Van, L. T., Van, C. T., Thi, N. P., Phuong, T. T. T., Thi, D. N., et al. (2019) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02462-x · Cited by 8
“tive dysfunction eventually leading to death (Evans et al. 1989).”
Preexisting dementia is associated with higher mortality rate in patients with femoral neck fracture
Rajeev, A. S., Ali, M., Tuinebreijer, W. E., Zourob, E., & Anto, J. (2021) · Aging Medicine · doi:10.1002/agm2.12142 · Cited by 7
Mitochondria in Neurodegeneration
Swerdlow, R. H. (2011) · Advances in neurobiology · doi:10.1007/978-1-4614-1788-0_30 · Cited by 7
Donepezil (Aricept®) treatment of multi infarct dementia: The caregivers and clinical impression
Shua‐Haim, J. R., Shua-Haim, V., Comsti, E., & Ross, J. (2000) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750001500408 · Cited by 7
Clinical Experiences and Methodologic Challenges in Conducting Clinical Trials on the Behavioral Disturbances of Dementia
Finkel, S. I., & Cooler, C. (1996) · International Psychogeriatrics · doi:10.1017/s1041610297003311 · Cited by 7
“community-based people older than the age of 65 years are believed to have Alzheimer’s disease (Evans et al., 1989).”
Background
The relationship between the minor allele content and Alzheimer's disease
Chen, H., Lei, X., Yuan, D., & Huang, S. (2020) · Genomics · doi:10.1016/j.ygeno.2020.01.015 · Cited by 7
Heterogeneity in Alzheimer's disease: evidence from cellular radiosensitivity and complementation of this phenotype
Chen, P. P., Kidson, C., & Lavin, M. F. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90029-b · Cited by 7
Risperidone for the Treatment of Neuropsychiatric Features in Dementia
Burns, A. S., & Deyn, P. P. D. (2006) · Drugs & Aging · doi:10.2165/00002512-200623110-00004 · Cited by 7
The prevalence of dementia: The confusion of numbers
Blume, L., Persily, N. A., & Mintzer, J. E. (1992) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331759200700302 · Cited by 7
Estrogen Replacement Therapy for Cognitive Benefits: Viable Treatment or Forgettable ???Senior Moment????
Marks, S. J., Batra, R. R., & Frishman, W. H. (2002) · Heart Disease · doi:10.1097/00132580-200201000-00005 · Cited by 7
Primary degenerative dementia of the Alzheimer type in twins: Initial findings from the Maudsley Hospital Twin Register
Karlinsky, H., Macdonald, A. M., & Berg, J. M. (1992) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930070811 · Cited by 7
The Etiology of Alzheimer's Disease: The Pathogenesis of Dementiaa The Role of Neurotoxins
Drachman, D. A., & Lippa, C. F. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24536.x · Cited by 7
Economic Analysis of Alzheimer’s Disease in Outpatients: Impact of Symptom Severity
Souêtre, E., Qing, W., Vigoureux, I., et al. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_78 · Cited by 7
Response to Tacrine in Patients with Dementia of the Alzheimer's Type: Cerebral Perfusion Change is Related to Change in Mental Status
Harkins, S. W., Taylor, J. R., & Mattay, V. S. (1996) · International Journal of Neuroscience · doi:10.3109/00207459608987260 · Cited by 7
Alzheimer's: A decade of progress, a future of nursing challenges
Abraham, I. L., & Neundorfer, M. M. (1990) · Geriatric Nursing · doi:10.1016/s0197-4572(06)80094-7 · Cited by 7
Predictors of Case Management for Persons with Alzheimer's Disease
Ginther, S. D., Webber, P. A., Fox, P. J., et al. (1993) · Journal of Applied Gerontology · doi:10.1177/073346489301200202 · Cited by 7
The Behavioral-Cognitive Model of Pain
Manetto, C., & McPherson, S. E. (1996) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30211-8 · Cited by 7
Assessing cognitive impairment in an ethnically diverse cohort of oldest-old: the life after 90 study
Petrosyan, D., Corrada, M. M., Kawas, C. H., Demoz, A., Ganzon, C., Popovich, O., Gaied, R., Mungas, D., Gilsanz, P., Vieira, K. E., et al. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02368-0 · Cited by 8
“One of the strengths of this study is the detailed in home assessment performed by the clinicians with clinical adjudication by a behavioral neurologist similar to that used in the East Boston Dementia study [32] and refined by experience in the 90 + study [3].”
Method
Related Genes and Potential Biomarkers for Early Diagnosis of Alzheimer’s Disease
Lin, H., Zhang, T., Wu, Y., Wang, Y., Wang, W., & Wang, Q. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513506774 · Cited by 6
Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms
Kagerer, S. M., Awasthi, S., Ripke, S., Maceski, A. M., Benkert, P., Fall, A. B., Riederer, P. F., Fischer, P. A., Walitza, S., Grünblatt, E., et al. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12504 · Cited by 6
Competence and Other Legal Issues
Haldipur, C. V., & Ward, M. S. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0295-5_6 · Cited by 6
Empirically Derived Trajectories to Dementia Over 15 Years of Follow-up Identified by Using Mixed Membership Models
Lecci, F., Junker, B. W., Kuller, L. H., López, O. L., & Becker, J. T. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv051 · Cited by 6
A Study of Dementia in Home Care Patients in Qatar with the Psychosocial Burden on Caregivers
Sulaiti, E. M. A., Abdelnour, S., & Ramadan, M. (2008) · Qatar medical journal · doi:10.5339/qmj.2008.1.15 · Cited by 6

Authors: Evans, D. A.
Corresponding author: Evans, Denis A.
ORCID: Evans, Denis A.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 1989-11-10
Volume: 262
Issue: 18
Pages: 2551
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1989.03430180093036
OpenAlex: W2129678592
Cited by: 1,226
References: 0
Citations by year: 2026: 6 · 2025: 11 · 2024: 13 · 2023: 15 · 2022: 9 · 2021: 20 · 2020: 22 · 2019: 17 · 2018: 20 · 2017: 18 · 2016: 28 · 2015: 23 · 2014: 17 · 2013: 32 · 2012: 25
FWCI: 44.57
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Funders: National Institute on Aging (N01-AG02107, N01‐AG‐1‐2106, AG 06789)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Aging, Health, and Disability
Keywords: Alzheimer's disease, prevalence, older adults, dementia, age-related cognitive decline, community-dwelling older adults, cognitive impairment, age differences in prevalence, public health impact

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence of Alzheimer's Disease in a Community Population of Older Persons: Higher Than Previously Reported

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks